Antipsychotic treatment of UHR ('prodromal') individuals

被引：15
|
作者：
Yung, Alison R. [1 ]
机构：
[1] Univ Melbourne, Orygen Youth Hlth Res Ctr, Ctr Youth Mental Hlth, Parkville, Vic 3052, Australia
来源：
EARLY INTERVENTION IN PSYCHIATRY | 2010年 / 4卷 / 03期
关键词：
ULTRA-HIGH RISK; RANDOMIZED CONTROLLED-TRIAL; PSYCHOTIC-LIKE EXPERIENCES; YOUNG-PEOPLE; 1ST EPISODE; DISORDERS; SCHIZOPHRENIA; INTERVENTIONS; PREDICTION; SYMPTOMS;
D O I：
10.1111/j.1751-7893.2010.00191.x
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：197 / 199
页数：3
相关论文
共 50 条
  • [21] Assessment and treatment of individuals at high risk for psychosis
    Andreou, Christina
    Bailey, Barbara
    Borgwardt, Stefan
    BJPSYCH ADVANCES, 2019, 25 (03) : 177 - 184
  • [22] Antipsychotic medication in individuals at Clinical High Risk for Psychosis: what recommendations for clinicians?
    Di Lisi, Alessandro
    Pelizza, Lorenzo
    JOURNAL OF PSYCHOPATHOLOGY, 2023, 29 (3-4): : 110 - 116
  • [23] Network Level Structural Covariance in Individuals at Ultra-High Risk (UHR) for Psychosis
    Heinze, Kareen
    Nelson, Barnaby
    Yung, Alison R.
    Lin, Ashleigh
    Reniers, Renate L. E. P.
    Harrison, Ben
    Wood, Stephen J.
    BIOLOGICAL PSYCHIATRY, 2013, 73 (09) : 19S - 19S
  • [24] Antipsychotic type and correlates of antipsychotic treatment discontinuation in the outpatient treatment of schizophrenia
    Haro, JM
    Novick, D
    Belger, M
    Jones, PB
    EUROPEAN PSYCHIATRY, 2006, 21 (01) : 41 - 47
  • [25] Antipsychotic Drug Treatment in First-Episode Psychosis Should Patients be Switched to a Different Antipsychotic Drug After 2, 4, or 6 Weeks of Nonresponse?
    Derks, Eske M.
    Fleischhacker, W. Wolfgang
    Boter, Han
    Peuskens, Jozef
    Kahn, Rene S.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2010, 30 (02) : 176 - 180
  • [26] BDNF as a pharmacogenetic target for antipsychotic treatment of schizophrenia
    Han, Mei
    Deng, Chao
    NEUROSCIENCE LETTERS, 2020, 726
  • [27] Hyperglycemia with antipsychotic treatment
    Sathyaprakash R.
    Henry R.R.
    Current Diabetes Reports, 2004, 4 (1) : 41 - 45
  • [28] Validation of "prodromal" criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up
    Yung, Alison R.
    Nelson, Barnaby
    Stanford, Carrie
    Simmons, Magenta B.
    Cosgrave, Elizabeth M.
    Killackey, Eoin
    Phillips, Lisa J.
    Bechdolf, Andreas
    Buckby, Joe
    McGorry, Patrick D.
    SCHIZOPHRENIA RESEARCH, 2008, 105 (1-3) : 10 - 17
  • [29] Antipsychotic Treatment in People at Clinical High Risk for Psychosis
    Di Lisi, Alessandro
    Pupo, Simona
    Menchetti, Marco
    Pelizza, Lorenzo
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2024, 44 (05) : 502 - 508
  • [30] Reduced P3a amplitudes in antipsychotic naive first-episode psychosis patients and individuals at clinical high-risk for psychosis
    Mondragon-Maya, Alejandra
    Solis-Vivanco, Rodolfo
    Leon-Ortiz, Pablo
    Rodriguez-Agudelo, Yaneth
    Yanez-Tellez, Guillermina
    Bernal-Hernandez, Jorge
    Cadenhead, Kristin S.
    de la Fuente-Sandoval, Camilo
    JOURNAL OF PSYCHIATRIC RESEARCH, 2013, 47 (06) : 755 - 761
12345